Reviewing the Rationale for Cross-Shareholdings and Reducing Them
First written in FY2021. 3 of 4 entries say "Advanced", first in FY2024-Q2. Latest entry: FY2024.
- FY2024AdvancedAnnual report
「Shares other than unlisted shares 8 ¥4,576 million These shares were sold during the fiscal year following a review of the rationale for holding them.」
As a result of reviewing the rationale for its cross-shareholdings, the company sold 8 listed shareholdings during the fiscal year, for total proceeds of ¥4,576 million. - FY2024-Q3AdvancedAnnual report
「This resulted from the sale of domestic listed shares among the investment securities held by the company.」
The company recorded a gain on the sale of investment securities of ¥2,463 million from the sale of domestic listed shares. The filing does not explicitly state a direct connection with the reduction of cross-shareholdings. - FY2024-Q2AdvancedAnnual report
「The main cash flows were ¥4,372 million in proceeds from the sale of investment securities and ¥3,506 million in payments for the acquisition of property, plant and equipment.」
The company recorded ¥4,372 million in proceeds from the sale of investment securities. The filing does not explicitly state whether the sale constituted a reduction of cross-shareholdings. - FY2021First statedAnnual report
「The rationality of holding individual cross-shareholdings is reviewed regularly by the Board of Directors based on criteria such as the cost of capital. While engaging in dialogue and negotiations with business partners and others, the company will reduce holdings whose significance has diminished.」
For cross-shareholdings, the company stated for the first time, as a standalone policy, that the holdings would be reviewed regularly by the Board of Directors based on criteria such as the cost of capital, and that holdings whose significance has diminished would be reduced. During the fiscal year, it sold 6 listed shareholdings.